Compounds > physostigmine
Page last updated: 2024-08-17

physostigmine and Neuroleptic Malignant Syndrome

physostigmine has been researched along with Neuroleptic Malignant Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dahm, JB; Trenckmann, U1
Krull, F; Risse, A1

Other Studies

2 other study(ies) available for physostigmine and Neuroleptic Malignant Syndrome

ArticleYear
[Neuroleptic malignant syndrome].
    Medizinische Klinik (Munich, Germany : 1983), 1991, Nov-15, Volume: 86, Issue:11

    Topics: Adult; Antipsychotic Agents; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Male; Neuroleptic Malignant Syndrome; Physostigmine; Psychotic Disorders

1991
[A case of malignant neuroleptic syndrome with rhabdomyolysis and a therapeutic trial using physostigmine].
    Fortschritte der Neurologie-Psychiatrie, 1986, Volume: 54, Issue:12

    Topics: Adult; Antipsychotic Agents; Drug Therapy, Combination; Humans; Male; Neuroleptic Malignant Syndrome; Physostigmine; Rhabdomyolysis; Schizophrenia, Paranoid

1986